Mayo Clinic

Phoenix, Arizona 85259-5499

35 studies enrolling now · 191 studies all time

What they study most

Acral Lentiginous Melanoma, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute T Cell Leukemia Lymphoma, Adamantinomatous Craniopharyngioma, Adenocarcinoma Lung, Adenomatous Polyposis Coli, Adnexal Mass, Adult Solid Tumor, Advanced Cancer, Advanced Cutaneous Squamous Cell Carcinoma, Advanced Liver Cancer

Studies at this site

• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — Recruiting now
• Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) — Recruiting now
• A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement — Recruiting now
• Onyx™ Liquid Embolic IDE Clinical Study — Recruiting now
• FOG-001 in Locally Advanced or Metastatic Solid Tumors — Recruiting now
• DALY II USA/ MB-CART2019.1 for DLBCL — Recruiting now
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors — Recruiting now
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers — Recruiting now
• Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer — Recruiting now
• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) — Recruiting now
• A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness — Recruiting now
• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• Determining the Utility of a Behavioral Intervention in Chronic Migraine — Recruiting now
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer — Recruiting now
• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• Growth Hormone for the Treatment of Gastroparesis — Recruiting now
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor — Recruiting now
• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies — Recruiting now
• Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. — Recruiting now
• Evaluate the Safety and Clinical Activity of HH2853 — Recruiting now
• Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) — Recruiting now
• Blue Light Cystoscopy With Cysview® Registry — Recruiting now
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — Recruiting now
• PROMIS and Mobility Evaluation in Sarcoma Patients — Recruiting now
• Understanding of Genetics by Men at Risk for Prostate Cancer — Recruiting now
• Intent of Surgery for IPMN — Recruiting now
• Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors — Recruiting now
• Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors — Recruiting now
• DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors — Recruiting now
• An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma — Recruiting now
• Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. — Completed
• GEN1046 Safety Trial in Patients With Malignant Solid Tumors — Running, not enrolling
• Pivotal Study of Voro Urologic Scaffold — Running, not enrolling
• Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors — Completed
• A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors — Running, not enrolling
• Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma — Starting soon
• Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy — Completed
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Moral Distress, Moral Injury and Post-Traumatic Stress for Nurses — Enrolling by invitation
• Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial — Starting soon
• Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure — Stopped early
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM — Completed
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — Running, not enrolling
• Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma — Completed
• ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer — Available (expanded access)
• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling